The detection of the Philadelphia chromosome, i.e., 22q- or BCR-ABL1 transcripts or both, in peripheral blood or bone-marrow cells may be conclusive for CML diagnosis [24]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.